Diabetes complications

Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced Retinopathy

Diabetes CarePublished Longitudinal cohort study

Main finding · PDR (unadjusted)Result — go to the resultHazard ratio 1.51 95% CI 1.12–2.02

Authors' conclusion

These data suggest that individuals with any sign of retinopathy within the first 5 years of T1D onset may be at higher risk of long-term development of advanced DR, especially PDR. Identification of early-onset DR may influence prognosis and help guide therapeutic management to reduce the risk of future visual loss in these individuals.

Study context

Population
Individuals with T1D, diabetic retinopathy (DR) assessed longitudinally by fundus photography at intervals of 6 months to 4 years
Participants
484 vs 369
Exposure
Early-onset DR vs no EDR
  • EDRn = 484
  • No EDRn = 369reference
Outcome
Subsequent risk of PDR, CSME, diabetes-related retinal photocoagulation
Methodological detailsstandardized stereoscopic seven-field fundus photography, Cox models
  • Standardized stereoscopic seven-field fundus photography
  • Cox models

Main finding

PDR (unadjusted)

Hazard ratio

1.51

95% CI 1.12–2.02

P = 0.006

EDRvs No EDR
HR 1.51 (95% CI 1.12–2.02); P = 0.006

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHRP value
CSME (unadjusted)Unadjusted1.44 (CI 1.10–1.88)P = 0.008
Diabetes-related retinal photocoagulation (unadjusted)Unadjusted1.48 (CI 1.12–1.96)P = 0.006
PDR, fully adjusted (age, T1D duration, HbA1c, sex, BP, pulse, ACE inhibitors, albumin excretion rate, eGFR)Fully adjusted; only PDR association remained significant1.47 (95% CI 1.04–2.06)P = 0.028

Proliferative diabetic retinopathy (PDR), clinically significant macular edema (CSME), photocoagulation adjusted for HbA1c

Associations remained significant when adjusted for HbA1c

Original publication

Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced Retinopathy. Diabetes Care. Published 13 December 2022. doi:10.2337/dc22-1711

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.